Home/Filings/4/0001104659-24-014614
4//SEC Filing

Komjathy Andrew 4

Accession 0001104659-24-014614

CIK 0001454789other

Filed

Feb 11, 7:00 PM ET

Accepted

Feb 12, 4:05 PM ET

Size

5.8 KB

Accession

0001104659-24-014614

Insider Transaction Report

Form 4
Period: 2024-02-08
Komjathy Andrew
Chief Commercial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-02-08+175,000175,000 total
    Exercise: $15.26Exp: 2034-02-07Common Stock (175,000 underlying)
Footnotes (1)
  • [F1]This option was granted on February 8, 2024 and is subject to vesting over a four-year period, with 25% of the 175,000 shares underlying the option upon grant vesting on the first anniversary of February 8, 2024 and the remainder vesting over the ensuing three years in equal monthly installments.

Issuer

Astria Therapeutics, Inc.

CIK 0001454789

Entity typeother

Related Parties

1
  • filerCIK 0001788465

Filing Metadata

Form type
4
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 4:05 PM ET
Size
5.8 KB